{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:59:05Z","timestamp":1794031145313,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-12784-9","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:46:15Z","timestamp":1749026775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The organizational dimension in rare and complex diseases care management: an application of RarERN Path\u00a9 methodology in ataxias, dystonia and phenylketonuria"],"prefix":"10.1186","volume":"25","author":[{"given":"Sara","family":"Cannizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinciane","family":"Quoidbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Trieste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Filla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette Sheehan","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holm","family":"Grae\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hagedorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Hermida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Morgante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martje G.","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Relja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Treacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francjan","family":"Van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vallortigara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1877-5459","authenticated-orcid":false,"given":"Giuseppe","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"2","key":"12784_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12687-021-00520-9","volume":"12","author":"B Tumiene","year":"2021","unstructured":"Tumiene B, Graessner H. Rare disease care pathways in the EU: from odysseys and labyrinths towards highways. J Community Genet. 2021;12(2):231\u20139. https:\/\/doi.org\/10.1007\/s12687-021-00520-9. Epub 2021 Mar 18. PMID: 33738760; PMCID: PMC8141079.","journal-title":"J Community Genet"},{"issue":"8","key":"12784_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/ene.14302","volume":"27","author":"C Painous","year":"2020","unstructured":"Painous C, van Os NJH, Delamarre A, Michailoviene I, Marti MJ, van de Warrenburg BP, Meissner WG, Utkus A, Reinhard C, Graessner H, Tijssen MA. Management of rare movement disorders in Europe: outcome of surveys of the European reference network for rare neurological diseases. Eur J Neurol. 2020;27(8):1493\u2013500. https:\/\/doi.org\/10.1111\/ene.14302. Epub 2020 Jun 19. PMID: 32386078; PMCID: PMC7496702.","journal-title":"Eur J Neurol"},{"issue":"Spec Ed Integra","key":"12784_CR3","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.5334\/ijic.812","volume":"12","author":"G Schrijvers","year":"2012","unstructured":"Schrijvers G, van Hoorn A, Huiskes N. The care pathway: concepts and theories: an introduction. Int J Integr Care. 2012;12(Spec Ed Integrated Care Pathways):e192. https:\/\/doi.org\/10.5334\/ijic.812. PMID: 23593066; PMCID: PMC3602959.","journal-title":"Int J Integr Care"},{"issue":"Suppl 1","key":"12784_CR4","doi-asserted-by":"publisher","first-page":"e000794","DOI":"10.1136\/rmdopen-2018-000794","volume":"4","author":"S Cannizzo","year":"2018","unstructured":"Cannizzo S, Lorenzoni V, Palla I, Pirri S, Trieste L, Triulzi I, Turchetti G. Rare diseases under different levels of economic analysis: current activities, challenges and perspectives. RMD Open. 2018;4(Suppl 1):e000794. https:\/\/doi.org\/10.1136\/rmdopen-2018-000794. PMID: 30488003; PMCID: PMC6241967.","journal-title":"RMD Open"},{"key":"12784_CR5","unstructured":"European Pathway Association. https:\/\/e-p-a.org\/care-pathways\/. Accessed 26 Apr 2025."},{"issue":"1","key":"12784_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0163278711407313","volume":"35","author":"T Rotter","year":"2012","unstructured":"Rotter T, Kinsman L, James E, Machotta A, Willis J, Snow P, Kugler J. The effects of clinical pathways on professional practice, patient outcomes, length of stay, and hospital costs: Cochrane systematic review and meta-analysis. Eval Health Prof. 2012;35(1):3\u201327. Epub 2011 May 24. PMID: 21613244.","journal-title":"Eval Health Prof"},{"issue":"1","key":"12784_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13023-021-01778-5","volume":"16","author":"R Talarico","year":"2021","unstructured":"Talarico R, Cannizzo C, Lorenzoni V, Marinello D, Palla I, Pirri S, Ticciati S, Trieste S, Triulzi I, Terol E, Bucher A, Turchetti G. Correction to: rarern path\u2122: a methodology towards the optimisation of patients\u2019 care pathways in rare and complex diseases developed within the European reference networks. Orphanet J Rare Dis. 2021;16(1):146. https:\/\/doi.org\/10.1186\/s13023-021-01778-5. Erratum for: Orphanet J Rare Dis. 2020;15(1):347. PMID: 33752690; PMCID: PMC7986507.","journal-title":"Orphanet J Rare Dis"},{"key":"12784_CR8","doi-asserted-by":"publisher","first-page":"935014","DOI":"10.3389\/frhs.2022.935014","volume":"2","author":"R Talarico","year":"2022","unstructured":"Talarico R, Marinello D, Cannizzo S, Palla I, Ticciati S, Gaglioti A, Rys A, Milli C, Taruscio D, Mosca M, Turchetti G. An opportunity to harmonise the approach to patients\u2019 care pathways for rare and complex diseases: rarern path\u2122. Front Health Serv. 2022;2:935014. https:\/\/doi.org\/10.3389\/frhs.2022.935014.","journal-title":"Front Health Serv"},{"key":"12784_CR9","unstructured":"EBC European Research Project\u2013. The Value Of Treatment for brain disorders in Europe. https:\/\/www.braincouncil.eu\/projects-and-initiatives\/vot2\/. Accessed 26 Apr 2025."},{"key":"12784_CR10","unstructured":"ORPHANET classification of rare neurological diseases\u2013ataxias. ORPHA:102002. https:\/\/www.orpha.net\/consor4.01\/www\/cgi-bin\/Disease_Classif.php?lng=EN&data_id=181&PatId=14938&search=Disease_Classif_Simple&new=1. Accessed 26 Apr 2025."},{"issue":"1","key":"12784_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-019-1013-9","volume":"14","author":"R de Silva","year":"2019","unstructured":"de Silva R, Greenfield J, Cook A, Bonney H, Vallortigara J, Hunt B, Giunti P. Guidelines on the diagnosis and management of the progressive ataxias. Orphanet J Rare Dis. 2019;14(1):51. https:\/\/doi.org\/10.1186\/s13023-019-1013-9. PMID: 30786918; PMCID: PMC6381619.","journal-title":"Orphanet J Rare Dis"},{"key":"12784_CR12","unstructured":"ORPHANET classification of rare neurological diseases\u2013 dystonia - ORPHA:98006. https:\/\/www.orpha.net\/consor4.01\/www\/cgi-bin\/Disease_Classif.php?lng=EN&data_id=181&PatId=10502&search=Disease_Classif_Simple&new=1. Accessed 26 Apr 2025."},{"key":"12784_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00415-022-11412-4","volume":"270","author":"LM Centen","year":"2023","unstructured":"Centen LM, Pinter D, van Egmond ME, et al. Dystonia management across Europe within ERN-RND: current state and future challenges. J Neurol. 2023;270:797\u2013809.","journal-title":"J Neurol"},{"key":"12784_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1750-1172-8-191","volume":"8","author":"TS Hagedorn","year":"2013","unstructured":"Hagedorn TS, van Berkel P, Hammerschmidt G, Lhot\u00e1kov\u00e1 M, Saludes RP. Requirements for a minimum standard of care for phenylketonuria: the patients\u2019 perspective. Orphanet J Rare Dis. 2013;8:191. https:\/\/doi.org\/10.1186\/1750-1172-8-191. PMID: 24341788; PMCID: PMC3878574.","journal-title":"Orphanet J Rare Dis"},{"key":"12784_CR15","unstructured":"ERN ReCONNET. RarERN Path. https:\/\/reconnet.ern-net.eu\/rarern-path\/. Accessed 26 Apr 2025."},{"key":"12784_CR16","doi-asserted-by":"publisher","unstructured":"Palla I, Turchetti G, Polvani S. Narrative medicine: theory, clinical practice and education - a scoping review. BMC Health Serv Res. 2024;24(1). https:\/\/doi.org\/10.1186\/s12913-024-11530-x.","DOI":"10.1186\/s12913-024-11530-x"},{"issue":"3","key":"12784_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/practneurol-2018-002096","volume":"19","author":"RN de Silva","year":"2019","unstructured":"de Silva RN, Vallortigara J, Greenfield J, Hunt B, Giunti P, Hadjivassiliou M. Diagnosis and management of progressive ataxia in adults. Pract Neurol. 2019;19(3):196\u2013207. https:\/\/doi.org\/10.1136\/practneurol-2018-002096. Epub 2019 May 2. PMID: 31048364; PMCID: PMC6585307.","journal-title":"Pract Neurol"},{"issue":"3","key":"12784_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11940-019-0549-2","volume":"21","author":"CD Stephen","year":"2019","unstructured":"Stephen CD, Brizzi KT, Bouffard MA, Gomery P, Sullivan SL, Mello J, MacLean J, Schmahmann JD. The Comprehensive Management of Cerebellar Ataxia in Adults. Curr Treat Options Neurol. 2019;21(3):9. PMID: 30788613. https:\/\/doi.org\/10.1007\/s11940-019-0549-2.","journal-title":"Curr Treat Options Neurol"},{"key":"12784_CR19","unstructured":"ERN RND. Diagnostic Flowchart for adult ataxias. https:\/\/www.ern-rnd.eu\/wp-content\/uploads\/2019\/08\/ERN-RND-Diagnostic-FlowchartAtaxia_FINAL.pdf. Accessed 26 Apr 2025."},{"issue":"2","key":"12784_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3325\/cmj.2019.60.156","volume":"60","author":"P Giunti","year":"2019","unstructured":"Giunti P, Morris S, Relja M, Pastores G, Quoidbach V. Toward earlier diagnosis and treatment of rare neurological disorders: the value of coordinated care and specialist centers. Croat Med J. 2019;60(2):156\u20137. https:\/\/doi.org\/10.3325\/cmj.2019.60.156.","journal-title":"Croat Med J"},{"issue":"1","key":"12784_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ene.13762","volume":"26","author":"A Albanese","year":"2019","unstructured":"Albanese A, Di Giovanni M, Lalli S. Dystonia: diagnosis and management. Eur J Neurol. 2019;26(1):5\u201317. https:\/\/doi.org\/10.1111\/ene.13762. Epub 2018 Aug 18. PMID: 30035844.","journal-title":"Eur J Neurol"},{"issue":"1","key":"12784_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ncl.2014.09.002","volume":"33","author":"HA Jinnah","year":"2015","unstructured":"Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurol Clin. 2015;33(1):77\u2013100. https:\/\/doi.org\/10.1016\/j.ncl.2014.09.002.","journal-title":"Neurol Clin"},{"key":"12784_CR23","doi-asserted-by":"publisher","first-page":"646841","DOI":"10.3389\/fneur.2021.646841","volume":"12","author":"M Smit","year":"2021","unstructured":"Smit M, Albanese A, Benson M, Edwards MJ, Graessner H, Hutchinson M, Jech R, Krauss JK, Morgante F, P\u00e9rez Due\u00f1as B, Reilly RB, Tinazzi M, Contarino MF, Tijssen MAJ, Collaborative Working Group. Dystonia management: what to expect from the future?? The perspectives of patients and clinicians within dystonia net Europe. Front Neurol. 2021;12:646841. https:\/\/doi.org\/10.3389\/fneur.2021.646841. PMID: 34149592; PMCID: PMC8211212.","journal-title":"Front Neurol"},{"issue":"5","key":"12784_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/nu14051021","volume":"14","author":"MI Gama","year":"2022","unstructured":"Gama MI, Pinto A, Daly A, Rocha JC, MacDonald A. The impact of the quality of nutrition and lifestyle in the reproductive years of women with PKU on the Long-Term health of their children. Nutrients. 2022;14(5):1021. https:\/\/doi.org\/10.3390\/nu14051021. PMID: 35267995; PMCID: PMC8912747.","journal-title":"Nutrients"},{"issue":"11","key":"12784_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/healthcare9111407","volume":"9","author":"V Rovelli","year":"2021","unstructured":"Rovelli V, Zuvadelli J, Paci S, Ercoli V, Re Dionigi A, Selmi R, Salvatici E, Cefalo G, Banderali G. Telehealth and COVID-19: empowering standards of management for patients affected by phenylketonuria and hyperphenylalaninemia. Healthc (Basel). 2021;9(11):1407. https:\/\/doi.org\/10.3390\/healthcare9111407. PMID: 34828453; PMCID: PMC8622759.","journal-title":"Healthc (Basel)"},{"issue":"1","key":"12784_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-022-02270-4","volume":"17","author":"M Benson","year":"2022","unstructured":"Benson M, Albanese A, Bhatia KP, Cavillon P, Cuffe L, K\u00f6nig K, Reinhard C, Graessner H. Development of a patient journey map for people living with cervical dystonia. Orphanet J Rare Dis. 2022;17(1):130. https:\/\/doi.org\/10.1186\/s13023-022-02270-4. PMID: 35313909; PMCID: PMC8935780.","journal-title":"Orphanet J Rare Dis"},{"key":"12784_CR27","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.ymgmr.2020.100571","volume":"23","author":"J Beazer","year":"2020","unstructured":"Beazer J, Breck J, Eggerding C, Gordon P, Hacker S, Thompson A, PKU Lost to Follow-Up Recommendations Group. Strategies to engage lost to follow-up patients with phenylketonuria in the united States: best practice recommendations. Mol Genet Metab Rep. 2020;23:100571. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100571. PMID: 32140415; PMCID: PMC7044524.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"12784_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/03007995.2020.1847717","volume":"37","author":"A Burlina","year":"2021","unstructured":"Burlina A, Leuzzi V, Spada M, Carbone MT, Paci S, Tummolo A. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers. Curr Med Res Opin. 2021;37(3):411\u201321. Epub 2021 Feb 1. PMID: 33222540.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"12784_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.34763\/jmotherandchild.20202402si.2004.000010","volume":"24","author":"P Burgard","year":"2020","unstructured":"Burgard P. A holistic approach to the patients\/ families with inborn errors of metabolism. J Mother Child. 2020;24(2):65\u201372. https:\/\/doi.org\/10.34763\/jmotherandchild.20202402si.2004.000010. PMID: 33179604; PMCID: PMC8518098.","journal-title":"J Mother Child"},{"issue":"1","key":"12784_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s13023-021-02108-5","volume":"16","author":"C Rohde","year":"2021","unstructured":"Rohde C, Thiele AG, Baerwald C, Ascherl RG, Lier D, Och U, Heller C, Jung A, Sch\u00f6nherr K, Joerg-Streller M, Luttat S, Matzgen S, Winkler T, Rosenbaum-Fabian S, Joos O, Beblo S. Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy. Orphanet J Rare Dis. 2021;16(1):477. https:\/\/doi.org\/10.1186\/s13023-021-02108-5. PMID: 34794480; PMCID: PMC8600879.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"12784_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gi\u017cewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, van Rijn M, Trefz F, Walter JH, van Spronsen FJ. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162. https:\/\/doi.org\/10.1186\/s13023-017-0685-2. PMID: 29025426; PMCID: PMC5639803.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"12784_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-020-01647-7","volume":"16","author":"AMJ van Wegberg","year":"2021","unstructured":"van Wegberg AMJ, MacDonald A, Abeln D, Hagedorn TS, Lange E, Trefz F, van Vliet D, van Spronsen FJ. Patient\u2019s thoughts and expectations about centres of expertise for PKU. Orphanet J Rare Dis. 2021;16(1):2. https:\/\/doi.org\/10.1186\/s13023-020-01647-7. PMID: 33407655; PMCID: PMC7789756.","journal-title":"Orphanet J Rare Dis"},{"key":"12784_CR33","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.4081\/gc.2019.8769","volume":"5","author":"C Carlo Sabb\u00e0","year":"2019","unstructured":"Carlo Sabb\u00e0 C, Lenato GM, Custodero C, Suppressa P. Rare diseases in the elderly: a new perspective for the specialist in geriatrics. Geriatric Care. 2019;5:8769. https:\/\/doi.org\/10.4081\/gc.2019.8769.","journal-title":"Geriatric Care"},{"key":"12784_CR34","doi-asserted-by":"publisher","first-page":"101467","DOI":"10.1016\/j.rasd.2019.101467","volume":"69","author":"M Stewart","year":"2020","unstructured":"Stewart M, Schnabel A, Hallford DJ, McGillivray JA, Forbes D, Foster M, Shandley K, Gardam M, Austin DW. Challenging child behaviours positively predict symptoms of posttraumatic stress disorder in parents of children with autism spectrum disorder and rare diseases. Res Autism Spectr Disorders. 2020;69:101467. https:\/\/doi.org\/10.1016\/j.rasd.2019.101467.","journal-title":"Res Autism Spectr Disorders"},{"issue":"3","key":"12784_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41584-020-00565-z","volume":"17","author":"R Talarico","year":"2021","unstructured":"Talarico R, Aguilera S, Alexander T, Turchetti G, et al. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN reconnet. Nat Rev Rheumatol. 2021;17(3):177\u201384.","journal-title":"Nat Rev Rheumatol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12784-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12784-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12784-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:46:19Z","timestamp":1749026779000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12784-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12784"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12784-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The questionnaire respondents were both the expert clinicians and the top management of the national patients\u2019 associations. Based on their experience, they provided their expert opinion about the clinical and organizational challenges in improving disease-specific patient care pathways. The respondents involved were invited to complete the questionnaire by email. Except for the research team members and authors of this work, no personally identifiable data was collected during the project. The results discussed in this manuscript are based on voluntary research and do not involve experimental research on human subjects or the use of human tissue samples. Hence, ethical approval and informed consent procedures were not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"799"}}